10.04.23
Booth 3171
At SupplySide West, international probiotics specialist Probiotical will showcase its strains and blends, and will take part in educating the industry on trends in research on the gut-brain axis.
The gut-brain axis is responsible for connections between the gut and emotional states, which can translate to sensations of discomfort, anxiety, and distress. It links the central nervous system with the gut, including microbiota and a wide range of metabolites and chemical signals it generates.
On October 26 at 2:00 p.m., Marco Pane, chief science officer, will present “Mindful Microbes: Probiotics for Mood and Sleep” at the supplier presentation theater. Pane has an MSc in food biotechnology/microbiology and is completing his PhD, and is a member of the International Probiotic Association Scientific and Manufacturing Committee, a board director at the Pharmabiotic Research Institute, and is a member of the Expert Panel on Probiotics within the US Pharmacopoeia. He has been a co-author on over 20 clinical trials involving probiotics.
In this presentation, Pane will explore the impact of probiotics on various aspects of gut and brain health, including metabolomics, mood regulation, sleep patterns, and the biochemical agents circulating within us, with the potential to transform mood, measures of quality of life, sleep, and wakefulness.
Probiotical’s experts will be on hand to discuss the current product line, which includes more than 60 strains and over 600 custom blends currently in production, as well as a bio-portfolio of over 2,000 strains and 80 families of patents.
Bifizen in the New Product Zone
Bifizen, a proprietary four-strain probiotic, will be featured in the new products zone window display. The ingredient was recently subject to a follow-up placebo-controlled study published in Frontiers in Nutrition which found that it had a beneficial effect on measures of subclinical/occasional depression, anxiety, and mood. Blood concentrations of serotonin were also significantly higher after six weeks of treatment compared to placebo, and also remained elevated after a three-week washout period.
At SupplySide West, international probiotics specialist Probiotical will showcase its strains and blends, and will take part in educating the industry on trends in research on the gut-brain axis.
The gut-brain axis is responsible for connections between the gut and emotional states, which can translate to sensations of discomfort, anxiety, and distress. It links the central nervous system with the gut, including microbiota and a wide range of metabolites and chemical signals it generates.
On October 26 at 2:00 p.m., Marco Pane, chief science officer, will present “Mindful Microbes: Probiotics for Mood and Sleep” at the supplier presentation theater. Pane has an MSc in food biotechnology/microbiology and is completing his PhD, and is a member of the International Probiotic Association Scientific and Manufacturing Committee, a board director at the Pharmabiotic Research Institute, and is a member of the Expert Panel on Probiotics within the US Pharmacopoeia. He has been a co-author on over 20 clinical trials involving probiotics.
In this presentation, Pane will explore the impact of probiotics on various aspects of gut and brain health, including metabolomics, mood regulation, sleep patterns, and the biochemical agents circulating within us, with the potential to transform mood, measures of quality of life, sleep, and wakefulness.
Probiotical’s experts will be on hand to discuss the current product line, which includes more than 60 strains and over 600 custom blends currently in production, as well as a bio-portfolio of over 2,000 strains and 80 families of patents.
Bifizen in the New Product Zone
Bifizen, a proprietary four-strain probiotic, will be featured in the new products zone window display. The ingredient was recently subject to a follow-up placebo-controlled study published in Frontiers in Nutrition which found that it had a beneficial effect on measures of subclinical/occasional depression, anxiety, and mood. Blood concentrations of serotonin were also significantly higher after six weeks of treatment compared to placebo, and also remained elevated after a three-week washout period.